Legend Biotech (LEGN) Revenue (2019 - 2025)

Legend Biotech's Revenue history runs 7 years deep, the most recent figure standing at $306.3 million for Q4 2025.

• Quarterly Revenue rose 64.24% year-over-year to $306.3 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $1.0 billion (up 64.02% YoY) and the FY2025 annual result came in at $1.0 billion, up 64.02% from the prior year.
• Revenue was $306.3 million for Q4 2025 at Legend Biotech, up from $272.3 million in the prior quarter.
• Across five years, Revenue topped out at $79.5 billion in Q4 2023 and bottomed at $12.0 million in Q2 2022.
• A 5-year average of $4.1 billion and a median of $83.7 million in 2023 frame the typical range for Revenue.
• Annual changes were most pronounced in 2023 — Revenue jumped 287469.21% — and 2024, when it sank 99.77%.
• Legend Biotech's Revenue stood at $39.0 million in 2021, then slipped by 29.14% to $27.6 million in 2022, then soared by 287469.21% to $79.5 billion in 2023, then sank by 99.77% to $186.5 million in 2024, then surged by 64.24% to $306.3 million in 2025.
• Business Quant data shows LEGN's Revenue at $306.3 million in Q4 2025, $272.3 million in Q3 2025, and $255.1 million in Q2 2025.